Expression of an engineered soluble Coxsackievirus and Adenovirus Receptor by a dimeric AAV9 vector inhibits Adenovirus infection in mice

被引：0
|
作者：
Roeger, C. [1 ]
Pozzuto, T. [1 ]
Klopfleisch, R. [2 ]
Kurreck, J. [1 ]
Fechner, H. [1 ]
Pinkert, S. [1 ]
机构：
[1] Tech Univ Berlin, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
来源：
HUMAN GENE THERAPY | 2015年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P272
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 33 条
  • [1] Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice
    C Röger
    T Pozzuto
    R Klopfleisch
    J Kurreck
    S Pinkert
    H Fechner
    Gene Therapy, 2015, 22 : 458 - 466
  • [2] Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice
    Roeger, C.
    Pozzuto, T.
    Klopfleisch, R.
    Kurreck, J.
    Pinkert, S.
    Fechner, H.
    GENE THERAPY, 2015, 22 (06) : 458 - 466
  • [3] AAV9 vector-mediated expression of a soluble coxsackievirus-adenovirus receptor inhibits coxsackievirus B3-induced chronic myocarditis in a therapeutic approach in mice
    Pinkert, S.
    Klopfleisch, R.
    Dieringer, B.
    Schmidtke, M.
    Savvatis, K.
    Fechner, H.
    HUMAN GENE THERAPY, 2015, 26 (10) : A106 - A107
  • [4] Differential expression of the coxsackievirus and adenovirus receptor regulates adenovirus infection of the placenta
    Koi, H
    Zhang, J
    Makrigiannakis, A
    Getsios, S
    MacCalman, CD
    Kopf, GS
    Strauss, JF
    Parry, S
    BIOLOGY OF REPRODUCTION, 2001, 64 (03) : 1001 - 1009
  • [5] Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus B3-mediated pancreatitis and myocarditis in mice
    Yanagawa, B
    Spiller, OB
    Proctor, DG
    Choy, J
    Luo, HL
    Zhang, HFM
    Suarez, A
    Yang, DC
    McManus, BM
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08): : 1431 - 1439
  • [6] Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection
    Fang Sun
    Yuxia Li
    Tianye Jia
    Yan Ling
    Long Liang
    Gang Liu
    Huipeng Chen
    Shan Chen
    Archives of Virology, 2012, 157 : 1101 - 1111
  • [7] Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection
    Sun, Fang
    Li, Yuxia
    Jia, Tianye
    Ling, Yan
    Liang, Long
    Liu, Gang
    Chen, Huipeng
    Chen, Shan
    ARCHIVES OF VIROLOGY, 2012, 157 (06) : 1101 - 1111
  • [8] Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor
    Pinkert, Sandra
    Westermann, Dirk
    Wang, Xiaomin
    Klingel, Karin
    Doerner, Andrea
    Savvatis, Konstantinos
    Groessl, Tobias
    Krohn, Stefanie
    Tschoepe, Carsten
    Zeichhardt, Heinz
    Kotsch, Katja
    Weitmann, Kerstin
    Hoffmann, Wolfgang
    Schultheiss, Heinz-Peter
    Spiller, O. Brad
    Poller, Wolfgang
    Fechner, Henry
    CIRCULATION, 2009, 120 (23) : 2358 - 2366
  • [9] Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells
    Carson, Steven D.
    Kim, Kyung-Soo
    Pirruccello, Samuel J.
    Tracy, Steven
    Chapman, Nora M.
    JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 3031 - 3038
  • [10] Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy
    Pinkert, Sandra
    Dieringer, Babette
    Klopfleisch, Robert
    Sawatis, Konstantinos
    Van Linthout, Sophie
    Pryshliak, Markian
    Tschoepe, Carsten
    Klingel, Karin
    Kurreck, Jens
    Beling, Antje
    Fechner, Henry
    CIRCULATION-HEART FAILURE, 2019, 12 (11)
1234